Waiting for Mifepristone

DSpace/Manakin Repository

dc.contributor.advisor	Hutt, Peter Barton	en_US
dc.contributor.author	Wilson, Lisa A.	en_US
dc.date.accessioned	2012-06-07T03:14:02Z
dc.date.issued	2000	en_US
dc.identifier.citation	Waiting for Mifepristone (2000 Third Year Paper)	en
dc.identifier.uri	http://nrs.harvard.edu/urn-3:HUL.InstRepos:8846769
dc.description.abstract	Physically, it is just a little white pill. But oh, what it could do: take abortion out of easily-identified clinics and disburse it to hospitals and doctor's offices, making what is so often called a "a private choice" actually private. And deprive pro-life activists of targets, publicity, and possibly support. For this potential to alter the current landscape, the New York Times Magazine has called it "The Little White Bombshell." But at the moment, RU-486 is available at only a handful of clinics throughout the country, while everyone else is waiting for final approval of the drug from the FDA.	en
dc.language.iso	en_US	en
dash.license	LAA	en_US
dc.subject	Food and Drug Law	en
dc.subject	RU-486	en
dc.subject	mifepristone	en
dc.subject	FDA	en
dc.title	Waiting for Mifepristone	en
dc.type	Paper (for course/seminar/workshop)	en_US
dc.date.available	2012-06-07T03:14:02Z